{"classification":[{"coding":[{"code":"nucleic-acid","display":"Nucleic Acid","system":"http://example.europa.eu/fhir/SubstanceType"}]}],"code":[{"code":{"coding":[{"code":"MIPO78654S","system":"http://example.europa.eu/fhir/Substance"}]}}],"description":"Mipomersen sodium — a synthetic second-generation 2'-methoxyethyl antisense oligonucleotide that inhibits the molecular target apolipoprotein B-100 (APOB-100). 20-mer phosphorothioate-linked sequence with 2'-MOE wing chemistry.","domain":{"coding":[{"code":"human","display":"Human use","system":"http://example.europa.eu/fhir/Domain"}]},"id":"mipomersen","identifier":[{"system":"http://example.europa.eu/fhir/SMSId","value":"MIPO78654S"}],"name":[{"language":[{"coding":[{"code":"en","display":"English","system":"urn:ietf:bcp:47"}]}],"name":"Mipomersen Sodium","official":[{"authority":{"coding":[{"code":"INN","display":"INN","system":"http://hl7.org/fhir/substance-name-authority"}]},"status":{"coding":[{"code":"active","display":"Active","system":"http://hl7.org/fhir/publication-status"}]}}],"preferred":true}],"nucleicAcid":{"gene":[{"gene":{"concept":{"coding":[{"code":"APOB","display":"apolipoprotein B","system":"http://www.genenames.org"}]}},"sequenceOrigin":{"coding":[{"code":"human","display":"Human","system":"http://hl7.org/fhir/gene-sequence-origin"}]}}],"numberOfSubunits":1,"oligoNucleotideType":{"coding":[{"code":"antisense","display":"Antisense oligonucleotide","system":"http://hl7.org/fhir/oligo-nucleotide-type"}]},"sequenceType":{"coding":[{"code":"complete","display":"Complete","system":"http://hl7.org/fhir/substance-sequence-type"}]},"subunit":[{"fivePrime":{"coding":[{"code":"G","display":"Guanosine","system":"http://hl7.org/fhir/nucleotide-terminus"}]},"length":20,"linkage":[{"residueSite":"1-19","substance":{"concept":{"coding":[{"code":"phosphorothioate","display":"Phosphorothioate linkage","system":"http://example.europa.eu/fhir/LinkageSubstance"}]}}}],"sequence":"GCCUCAGTCTGCTTCGCACC","subunit":1,"sugar":[{"residueSite":"1-5,16-20","substance":{"concept":{"coding":[{"code":"2-MOE","display":"2'-O-(2-methoxyethyl) ribose","system":"http://example.europa.eu/fhir/SugarSubstance"}]}}},{"residueSite":"6-15","substance":{"concept":{"coding":[{"code":"deoxyribose","display":"2'-deoxyribose","system":"http://example.europa.eu/fhir/SugarSubstance"}]}}}],"threePrime":{"coding":[{"code":"C","display":"Cytidine","system":"http://hl7.org/fhir/nucleotide-terminus"}]}}]},"relationship":[{"interaction":{"coding":[{"code":"inhibition","display":"Inhibition","system":"http://hl7.org/fhir/substance-interaction-type"}]},"substanceDefinitionCodeableConcept":{"coding":[{"code":"P04114","display":"apolipoprotein B-100","system":"https://www.uniprot.org"}]},"type":{"coding":[{"code":"TherapeuticTarget","display":"Therapeutic target","system":"http://hl7.org/fhir/substance-relationship-type"}]}}],"resourceType":"SubstanceDefinition","status":{"coding":[{"code":"active","system":"http://hl7.org/fhir/publication-status"}]}}